Accept or refuse? Factors influencing the decision-making of transplant surgeons who are offered a pancreas: results of a qualitative study

BMC Surgery

Martin Loss¹  Hans J Schlitt¹  Karl P Drewitz²  Julika Loss² 

[1] Department of Surgery, University Hospital Regensburg, Regensburg, Germany;Medical Sociology, University of Regensburg, Franz-Josef-Strauss-Allee 11, Regensburg D-93053, Germany

关键词: Refusal;    Allocation process;    Under-utilization;    Pancreas transplantation;   

Others  :  1123313
DOI  :  10.1186/1471-2482-13-47

 received in 2013-01-28, accepted in 2013-10-15,  发布年份 2013

【 摘 要 】

Background

Most offered pancreases are not transplanted. This study investigates the factors that inform and influence the transplant surgeon’s decision to select an offered pancreas.

Methods

Semi-standardized interviews were conducted with 14 highly qualified transplant surgeons from all 14 German transplant centers performing > 5 pancreas transplantations per year. The interviews focused on medical and non-medical criteria on which the individual accept/refuse decision depends. Interviews were recorded, transcribed and underwent content analysis.

Results

The interviewees agreed upon certain main selection criteria, e.g. donor age, lab results, ICU stay. However, there was no consistency in judging these parameters, and clear cut-offs did not exist. The pancreas macroscopy is a pivotal factor, as well as knowing (and trusting) the donor surgeon. 3/14 surgeons reported that they had occasionally refused a pancreas because of staff shortage. Some interviewees followed a restrictive acceptance policy, whereas others preferred to accept almost any pancreas and inspect it personally before deciding.

Conclusion

The assessment of medical donor characteristics is highly inconsistent. Both very cautious as well as very permissive acceptance policies may render the allocation process less efficient. A more standardized policy should be discussed. Finally, better training for donor surgeons seems advisable, in order to increase trust and thus pancreas utilization.

【 授权许可】

   
2013 Loss et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Landgraf R: Impact of pancreas transplantation on diabetic secondary complications and quality of life. Diabetologia 1996, 39(12):1415-1424.
• [2]Katz H, Homan M, Velosa J, Robertson P, Rizza R: Effects of pancreas transplantation on postprandial glucose metabolism. N Engl J Med 1991, 325(18):1278-1283.
• [3]Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM: Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003, 290(21):2817-2823.
• [4]Gruessner RWG, Sutherland DER, Gruessner AC: Mortality assessment for pancreas transplants. Am J Transplant 2004, 4(12):2018-2026.
• [5]Smets YF, Westendorp RG, van der Pijl JW, de Charro FT, Ringers J, de Fijter JW, Lemkes HH: Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 1999, 353(9168):1915-1919.
• [6]Ojo AO, Meier-Kriesche HU, Hanson JA, Leichtman A, Magee JC, Cibrik D, Wolfe RA, Port FK, Agodoa L, Kaufman DB, et al.: The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 2001, 71(1):82-90.
• [7]Oosterlee A, Rahmel AO: Eurotransplant international foundation annual report 2010. Leiden: Foundation EI; 2011.
• [8]Hudson AJ, Watson CJE, on behalf of the UK Transplant Pancreas Task Force: UK pancreas transplantation: Ten year trends and recent outcomes. In: British transplantation society (BTS). Belfast, Northern Ireland; 2005.
• [9]Loss M, Drewitz KP, Apfelbacher CJ, van Rosmalen MD, Rahmel A, Schlitt HJ, Loss J: Why offered pancreases are refused in the allocation process-a descriptive study using routine data from eurotransplant. Transplantation 2013, 95(9):1134-1141.
• [10]Howard DH: Why do transplant surgeons turn down organs? A model of the accept/reject decision. J Health Econ 2002, 21(6):957-969.
• [11]Deutsche Stiftung Organtransplantation: Organspende und transplantation in deutschland. Frankfurt/Main: Deutsche Stiftung Organtransplantation; 2010:2011.
• [12]Patton MQ: Qualitative evaluation and research methods. 2nd edition. Newbury Park: SAGE Publications; 1990.
• [13]Pope C, Ziebland S, Mays N: Qualitative research in health care. Analysing qualitative data. BMJ 2000, 320(7227):114-116.
• [14]Mays N, Pope C: Qualitative research in health care. Assessing quality in qualitative research. BMJ 2000, 320(7226):50-52.
• [15]Andreoni KA, Brayman KL, Guidinger MK, Sommers CM, Sung RS: Kidney and pancreas transplantation in the united states, 1996–2005. Am J Transplant 2007, 7(5):1359-1375.
• [16]Patton MQ: Qualitative research and evaluation methods. 3rd edition. Thousand Oaks, Calif: Sage Publications; 2002.
• [17]Wullstein C, Woeste G, de Vries E, Persijn GG, Bechstein WO: Acceptance criteria of pancreas grafts: how do surgeons decide in europe? Transplant Proc 2005, 37(2):1259-1261.
• [18]Wiseman AC, Wainright JL, Sleeman E, McBride MA, Baker T, Samana C, Stock P: An analysis of the lack of donor pancreas utilization from younger adult organ donors. Transplantation 2010, 90(5):475-480.
• [19]Farid S, Aldouri A, Fraser S, Al-Mukhtar A, Newstead C, Lewington A, Baker R, Menon K, Ahmad N: Outcomes of kidney grafts refused by one or more centers and subsequently transplanted at a single united kingdom center. Transplant Proc 2009, 41(5):1541-1546.
• [20]Wolfe RA, LaPorte FB, Rodgers AM, Roys EC, Fant G, Leichtman AB: Developing organ offer and acceptance measures: when ‘good’ organs are turned down. Am J Transplant 2007, 7(5 Pt 2):1404-1411.
• [21]Maglione M, Ploeg RJ, Friend PJ: Donor risk factors, retrieval technique, preservation and ischemia/reperfusion injury in pancreas transplantation. Curr Opin Organ Transplant 2013, 18(1):83-88.